The FDA Has a History of Rushed Drug Approvals
Two weeks ago, the Pfizer COVID-19 vaccine was reported as the first COVID-19 vaccine to receive full approval from the U.S. Food and Drug Administration (FDA) for individuals aged 16 and older.1 But, for some, questions remain regarding conflicting discrepancies of the wording surrounding the approval.2 While the FDA’s report states that full approval was […]
FDA Approves BioNTech’s Comirnaty. Pfizer COVID Shot Remains Experimental.
On Aug. 23, 2021, the U.S. Food and Drug Administration (FDA) gave full approval to a Biologics License Application (BLA) submitted by BioNTech Manufacturing GmbH of Mainz, Germany on May 18, 2021 for a biologic drug called COVID Vaccine, mRNA. The FDA gave permission to BioNTech to label the product “Comirnaty” and market it in […]
Jonathan Emord, JD on the Corruption Within the FDA
A significant minority of drugs that have been approved by the FDA have been approved over the FDA’s own medical reviewers’ objections on safety grounds. And the FDA’s whole system of drug review is bogus. It’s designed to protect and advance the interests of the drug industry. A lot of people don’t realize this but […]
Canada Adds Bell’s Palsy Warning to Pfizer COVID Shot
Health Canada, the Canadian government’s department responsible for national health policy, earlier this month updated the product information label for Pfizer/BioNTech’s experimental messenger RNA (mRNA) biologic (also known as BNT162b2 or “Comirnaty” vaccine) to reflect reported cases of Bell’s palsy—an immune mediated neurological disorder characterized by temporary muscle weakness or paralysis on one side of […]
Boy in Singapore Compensated for Heart Attack Linked to Pfizer’s COVID Biologic
Singapore’s Ministry of Health (MOH) announced on Aug. 16, 2021 that it had awarded S$225,000 (just over $165,000) to the family of a 16-year-old boy in Singapore who suffered a heart attack six days after receiving the first dose of Pfizer/BioNTech’s experimental messenger RNA (mRNA) COVID-19 biologic (also known as BNT162b2 or “Comirnaty” vaccine) on […]
Pfizer Raises Sales Forecast for COVID-19 Biologic to $33.5 Billion in 2021
Pfizer, Inc. reported that the company sold $7.8 billion worth of their COVID-19 biologic BNT162b2 in the second quarter of this year raising the company’s 2021 sales forecast for the two-dose vaccine to $33.5 billion from the previously estimated $26 billion.1 The $7.8 billion from direct sales of the shot is split with its German […]